SR 95531 (hydrobromide) |
A derivative of GABA that acts as an antagonist of GABAA receptors (Ki = 7… |
25 mg |
14585-25 |
More Info
|
SR 95531 (hydrobromide) |
A derivative of GABA that acts as an antagonist of GABAA receptors (Ki = 7… |
5 mg |
14585-5 |
More Info
|
SR 95531 (hydrobromide) |
A derivative of GABA that acts as an antagonist of GABAA receptors (Ki = 7… |
50 mg |
14585-50 |
More Info
|
SR 142948 (hydrochloride) |
A neurotensin receptor antagonist (IC50s = 1.19, 0.32, and 3.96 nM for hum… |
1 mg |
23911-1 |
More Info
|
SR 142948 (hydrochloride) |
A neurotensin receptor antagonist (IC50s = 1.19, 0.32, and 3.96 nM for hum… |
10 mg |
23911-10 |
More Info
|
SR 142948 (hydrochloride) |
A neurotensin receptor antagonist (IC50s = 1.19, 0.32, and 3.96 nM for hum… |
5 mg |
23911-5 |
More Info
|
SR 1555 (hydrochloride) |
A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… |
1 mg |
12071-1 |
More Info
|
SR 1555 (hydrochloride) |
A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… |
10 mg |
12071-10 |
More Info
|
SR 1555 (hydrochloride) |
A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… |
25 mg |
12071-25 |
More Info
|
SR 1555 (hydrochloride) |
A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… |
5 mg |
12071-5 |
More Info
|
(1S,3R)-3-Hydroxycyclopentane acetic acid |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11382-50 |
More Info
|
(1S,3R)-3-Hydroxycyclopentane acetic acid methyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11386-50 |
More Info
|
(1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11375-50 |
More Info
|
SRI-011381 |
An activator of TGF-β signaling; reduces increases in Aβ42-induc… |
1 mg |
28914-1 |
More Info
|
SRI-011381 |
An activator of TGF-β signaling; reduces increases in Aβ42-induc… |
10 mg |
28914-10 |
More Info
|
SRI-011381 |
An activator of TGF-β signaling; reduces increases in Aβ42-induc… |
5 mg |
28914-5 |
More Info
|
SRI-011381 |
An activator of TGF-β signaling; reduces increases in Aβ42-induc… |
500 µg |
28914-500 |
More Info
|
SRI-37330 |
A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… |
1 mg |
31638-1 |
More Info
|
SRI-37330 |
A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… |
10 mg |
31638-10 |
More Info
|
SRI-37330 |
A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… |
25 mg |
31638-25 |
More Info
|
SRI-37330 |
A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… |
5 mg |
31638-5 |
More Info
|
SR 717 (lithium salt) |
A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… |
10 mg |
31759-10 |
More Info
|
SR 717 (lithium salt) |
A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… |
25 mg |
31759-25 |
More Info
|
SR 717 (lithium salt) |
A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… |
5 mg |
31759-5 |
More Info
|
SR 717 (lithium salt) |
A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… |
50 mg |
31759-50 |
More Info
|
SRPIN340 |
An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… |
1 mg |
16284-1 |
More Info
|
SRPIN340 |
An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… |
10 mg |
16284-10 |
More Info
|
SRPIN340 |
An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… |
25 mg |
16284-25 |
More Info
|
SRPIN340 |
An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… |
5 mg |
16284-5 |
More Info
|
(1S,3R)-RSL3 |
A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… |
1 mg |
19288-1 |
More Info
|
(1S,3R)-RSL3 |
A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… |
10 mg |
19288-10 |
More Info
|
(1S,3R)-RSL3 |
A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… |
25 mg |
19288-25 |
More Info
|
(1S,3R)-RSL3 |
A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… |
5 mg |
19288-5 |
More Info
|
SRS11-92 |
A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… |
1 mg |
25689-1 |
More Info
|
SRS11-92 |
A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… |
10 mg |
25689-10 |
More Info
|
SRS11-92 |
A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… |
25 mg |
25689-25 |
More Info
|
SRS11-92 |
A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… |
5 mg |
25689-5 |
More Info
|
SRS16-86 |
An inhibitor of ferroptosis; inhibits erastin-induced ferroptosis in HT-10… |
1 mg |
26752-1 |
More Info
|
SRS16-86 |
An inhibitor of ferroptosis; inhibits erastin-induced ferroptosis in HT-10… |
5 mg |
26752-5 |
More Info
|
SRS16-86 |
An inhibitor of ferroptosis; inhibits erastin-induced ferroptosis in HT-10… |
500 µg |
26752-500 |
More Info
|
SRT 2104 |
A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… |
1 mg |
28380-1 |
More Info
|
SRT 2104 |
A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… |
10 mg |
28380-10 |
More Info
|
SRT 2104 |
A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… |
25 mg |
28380-25 |
More Info
|
SRT 2104 |
A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… |
5 mg |
28380-5 |
More Info
|
SRT 1720 (hydrochloride) |
A selective small molecule activator of SIRT1 that is 1,000-fold more pote… |
1 mg |
10011020-1 |
More Info
|
SRT 1720 (hydrochloride) |
A selective small molecule activator of SIRT1 that is 1,000-fold more pote… |
10 mg |
10011020-10 |
More Info
|
SRT 1720 (hydrochloride) |
A selective small molecule activator of SIRT1 that is 1,000-fold more pote… |
5 mg |
10011020-5 |
More Info
|
SRT 1720 (hydrochloride) |
A selective small molecule activator of SIRT1 that is 1,000-fold more pote… |
50 mg |
10011020-50 |
More Info
|
SRT 3025 (hydrochloride) |
A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… |
10 mg |
34420-10 |
More Info
|
SRT 3025 (hydrochloride) |
A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… |
100 mg |
34420-100 |
More Info
|
SRT 3025 (hydrochloride) |
A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… |
250 mg |
34420-250 |
More Info
|
SRT 3025 (hydrochloride) |
A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… |
50 mg |
34420-50 |
More Info
|
5(S),6(R)-11-trans DiHETE |
5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE… |
100 µg |
10009628-100 |
More Info
|
5(S),6(R)-11-trans DiHETE |
5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE… |
25 µg |
10009628-25 |
More Info
|
5(S),6(R)-11-trans DiHETE |
5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE… |
50 µg |
10009628-50 |
More Info
|
5(S),6(R)-7-trihydroxymethyl Heptanoate |
A potent bioactive analog of lipoxin A4; inhibits LTB4-induced chemotaxis… |
1 mg |
10005032-1 |
More Info
|
5(S),6(R)-7-trihydroxymethyl Heptanoate |
A potent bioactive analog of lipoxin A4; inhibits LTB4-induced chemotaxis… |
10 mg |
10005032-10 |
More Info
|
5(S),6(R)-7-trihydroxymethyl Heptanoate |
A potent bioactive analog of lipoxin A4; inhibits LTB4-induced chemotaxis… |
5 mg |
10005032-5 |
More Info
|
SS-208 |
An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… |
1 mg |
29128-1 |
More Info
|
SS-208 |
An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… |
10 mg |
29128-10 |
More Info
|
SS-208 |
An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… |
25 mg |
29128-25 |
More Info
|
SS-208 |
An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… |
5 mg |
29128-5 |
More Info
|
SSAA09E1 |
A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… |
1 mg |
32582-1 |
More Info
|
SSAA09E1 |
A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… |
10 mg |
32582-10 |
More Info
|
SSAA09E1 |
A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… |
25 mg |
32582-25 |
More Info
|
SSAA09E1 |
A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… |
5 mg |
32582-5 |
More Info
|
(1S,3S)-3-Aminomethyl-cyclopentanol |
A synthetic intermediate useful for pharmaceutical synthesis |
50 mg |
11358-50 |
More Info
|
(3S,5S)-Atorvastatin (sodium salt) |
An enantiomer of atorvastatin that has little or no inhibitory activity ag… |
1 mg |
18465-1 |
More Info
|
(3S,5S)-Atorvastatin (sodium salt) |
An enantiomer of atorvastatin that has little or no inhibitory activity ag… |
10 mg |
18465-10 |
More Info
|
(3S,5S)-Atorvastatin (sodium salt) |
An enantiomer of atorvastatin that has little or no inhibitory activity ag… |
5 mg |
18465-5 |
More Info
|
(1S,3S)-3-Benzoic acid 3-carboxycyclopentyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11364-50 |
More Info
|
10(S),17(S)-DiHDHA |
A DHA metabolite, also referred to as protectin DX (PDX), produced by an a… |
100 µg |
10008128-100 |
More Info
|
10(S),17(S)-DiHDHA |
A DHA metabolite, also referred to as protectin DX (PDX), produced by an a… |
25 µg |
10008128-25 |
More Info
|
10(S),17(S)-DiHDHA |
A DHA metabolite, also referred to as protectin DX (PDX), produced by an a… |
50 µg |
10008128-50 |
More Info
|
5(S),12(S)-DiHETE |
A natural bioactive lipid derived from AA |
100 µg |
35260-100 |
More Info
|